The Personalized Medicine Report: Opportunity, Challenges, and the Future

DownloadThe Personalized Medicine Report: Opportunity, Challenges, and the Future presents an overview of the state of personalized medicine with reference to the latest advancements in research and clinical care as well as the policy and clinical implementation challenges associated with the field. The report shows that the number of personalized medicines on the market in the United States has grown from 132 in 2016 to 286 in 2020, the largest four-year increase since the Coalition began tracking this figure in 2008.

With reference to new tools including liquid biopsies, gene therapies and advanced data analytics, the report underlines personalized medicine’s capacity to:

  • Shift the emphasis in medicine from reaction to prevention;
  • Direct targeted therapy and reduce trial-and-error prescribing;
  • Reduce the frequency and magnitude of adverse drug reactions;
  • Replace or circumvent aberrant molecular pathways associated with disease;
  • Reveal additional targeted uses for medicines and drug candidates;
  • Increase patient adherence to treatment;
  • Reduce high-risk invasive testing procedures;
  • Help to shift physician-patient engagement toward patient-centered care; and
  • Help to control the overall cost of health care.

Printed copies of this report are available to institutions interested in disseminating the publication to their own networks. For details, please contact PMC Vice President for Public Affairs Christopher J. Wells at

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today